Effective disease diagnosis relies on pathogen detection, which is crucial for identifying potential infections. Samples such as blood, urine, saliva, and stool are collected from symptomatic patients and analyzed using pathogenic detection assays. Commonly employed techniques for pathogen detection include polymerase chain reaction (PCR), culture and colony counting methods, and immunology-based methods. These methodologies involve DNA analysis, quantifying bacterial colonies, and studying the interactions between antigens and antibodies.
According to Data Bridge Market Research, the Pathogen Detection Market accounted for USD 4.9 billion in 2022 and is expected to reach USD 9.07 billion by 2030. The market is expected to grow with a CAGR of 8% in the forecast period of 2023 to 2030.
“Rising genetic testing technology”
The utilization of genetic testing technology has been on the rise for the rapid, sensitive, and dependable detection of pathogens in food. These testing techniques have the capability to identify pathogens even in their early stages or at low concentrations. For instance LexaGena, a Biotech startup that unveiled LX2, the world's first on-site, open access pathogen detection instrument for applications in food safety and veterinary diagnostics at a healthcare conference in San Francisco, California, in 2019. Currently, the company is in the process of developing the analyser for future market launches. Therefore, contributing to the market’s growth.
What restraints the growth of the pathogen detection market?
“High cost of identification tests”
The high cost of pathogen detection tests is acting as a restraint for the pathogen detection test market. The expenses involved in conducting these tests, including equipment, reagents, and laboratory facilities, can be substantial. This cost factor limits the accessibility and affordability of pathogen detection tests for many individuals and healthcare facilities. As a result, the market growth and adoption of these tests may be hindered, particularly in resource-constrained settings.
Segmentation: Pathogen Detection Market
The pathogen detection market is segmented on the basis of type, consistency, culture media, contaminant type, total count, food type, technology, customer type, application, end user, and distribution channel.
- On the basis of type, the pathogen detection market has been segmented into products, services.
- On the basis of consistency, the pathogen detection market has been segmented into solid media, liquid media.
- On the basis of culture media, the pathogen detection market has been segmented into chemical composition, synthetic media.
- On the basis of contaminant type, the pathogen detection market has been segmented into salmonella, e.coli, listeria, campylobacter, clostridium perfringens, pseudomonas, Cronobacter, coliforms, legionella, others.
- On the basis of total count, the pathogen detection market has been segmented into spoiling organisms, Yeast and moulds, others.
- On the basis of technology, the pathogen detection market has been segmented into rapid, traditional, other molecular-based tests.
- On the basis of customer type, the pathogen detection market has been segmented into service lab, industry, governmental/non-profit organization.
- On the basis of application, the pathogen detection market has been segmented into diagnostics, pathology, forensics, clinical research, drug discovery.
- On the basis of end user, the pathogen detection market has been segmented into pathology laboratories, diagnostic centers, hospitals, biotechnology companies, pharmaceutical companies, culture collection repositories, Cooling Towers, blood banks, others.
- On the basis of distribution channel, the pathogen detection market has been segmented into direct tender, retail sales.
Regional Insights: North America Dominates the Pathogen Detection Market
North America dominates the pathogen detection market due to substantial investments and strong demand for pathogen detection products and services solutions.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 the market growth is attributed to an increased focus on pathogen detection, indicating a growing concern in this area.
To know more about the study visit, https://www.databridgemarketresearch.com/de/reports/global-pathogen-detection-market
The Prominent Key Players Operating in the Pathogen Detection Market Include:
- Merck KGaA (Germany)
- Thermo Fisher Scientific Inc. (U.S.)
- BIOMÉRIEUX (France)
- Agilent Technologies, Inc. (U.S.)
- BD (U.S.)
- biotools (U.S.)
- SGS Société Générale de Surveillance SA (Switzerland)
- Bureau Veritas (India) Private Limited (India)
- Intertek Group plc (U.K.)
- Eurofins Scientific (Luxembourg)
- Mérieux NutriSciences Corporation (France)
- ifp Institut für Produktqualität GmbH (Germany)
- ALS (Australia)
- Microbac Laboratories, Inc. (U.S.)
- FoodChain ID Group, Inc (U.S.)
- AsureQuality (New Zealand)
- Campden BRI (U.K.)
- ANGLE plc (U.K.)
Above are the key players covered in the report, to know about more and exhaustive list of pathogen detection market companies contact, https://www.databridgemarketresearch.com/de/contact
Research Methodology: Global Pathogen Detection Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
